Morgan Stanley says alternative data through diet season has been “mixed, but far better than the stock price movement would imply” and the firm believes the recent selloff in WW shares is “disconnected with the data-informed outlook.” The firm is positive heading into the Q4 report and sees a “positively skewed” risk-reward with indications of a strong Q4 and limited changes to its estimates, adds the analyst, who maintains an Overweight rating and $13 price target on WW shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on WW:
- WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food
- Weight Watchers call volume above normal and directionally bullish
- DA Davidson keeps Buy on WW after selloff on Lilly news
- WW investors ‘overreacting’ to LillyDirect announcement, says Guggenheim
- Weight Watchers put volume heavy and directionally bearish